Temporal variability of Lp(a) in clinically stable patients: Implications for cardiovascular risk assessment
Authors:
- 20 July 2024
- journal article
- research article
- Published by Elsevier in Medicina Clinica
- Vol. 163 (9) , 436-441
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis SocietyAtherosclerosis, 2023
- Lipoprotein(a) variability over time in adult lipid clinic patientsAtherosclerosis, 2022
- Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill?Atherosclerosis, 2022
- Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA geneAtherosclerosis, 2022
- Lipoprotein(a) levels from childhood to adulthood: Data in nearly 3,000 children who visited a pediatric lipid clinicAtherosclerosis, 2022
- Repeat Measures of Lipoprotein(a) Molar Concentration and Cardiovascular RiskJACC, 2022
- Lipoprotein(a) and Cardiovascular DiseasesJAMA, 2021
- Temporal variability in lipoprotein(a) levels in patients enrolled in the placebo arms of IONIS-APO(a)Rx and IONIS-APO(a)-LRx antisense oligonucleotide clinical trialsJournal of Clinical Lipidology, 2018
- Oxidized Low-Density Lipoprotein in Children With Familial Hypercholesterolemia and Unaffected SiblingsJACC, 2006
- Estrogen and Progestin, Lipoprotein(a), and the Risk of Recurrent Coronary Heart Disease Events After MenopauseJAMA, 2000